Found 12 matching trials
Study of Eteplirsen in DMD Patients PHASE3 The main objective of this study is to provide evidence of efficacy of etep...
Show More Location
Neuromuscular Research Center
Learn More & Join Trial
Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy PHASE1 Duchenne muscular dystrophy (DMD), a fatal muscle degenerative disorder, ar...
Show More Location
Dubowitz Neuromuscular Centre, Hammersmith Hospital and Clinical Trails Unit, St Mary's Hospital
Learn More & Join Trial
Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients PHASE2 This study is designed to assess the efficacy, safety, tolerability, and ph...
Show More Location
Nationwide Children's Hospital
Learn More & Join Trial
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy PHASE2 The primary objective of this study is to assess the ongoing efficacy, safe...
Show More Location
Miller Children's Hospital
Learn More & Join Trial
A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice N/A This is a phase 4, multicenter, prospective, observational study designed t...
Show More Status
Enrolling By Invitation
Location
Arkansas Children's Hospital Research Institute
Learn More & Join Trial
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy PHASE2 This is an open-label study to assess the safety, tolerability, efficacy an...
Show More Location
Neuromuscular Research Center of Arizona
Learn More & Join Trial
A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications. PHASE2 This is an 48-week open-label study to determine the efficacy and safety of...
Show More Location
Nationwide Children's Hospital
Learn More & Join Trial
Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy PHASE2 The primary objective of this study is to explore safety and tolerability o...
Show More Location
Ronald Reagan UCLA Medical Center
Learn More & Join Trial
A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995) PHASE2 The purpose of this extension study is to evaluate the ongoing safety and t...
Show More Learn More & Join Trial
Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients PHASE1 The specific aim of this Phase I/II study is to assess the safety of intrav...
Show More Location
Great Ormond Street Hospital
Learn More & Join Trial